According to a newly published market research report by 24LifeSciences, global plexiform neurofibromas treatment market was valued at USD 350 million in 2024 and is projected to reach USD 780 million by 2032, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 2025-2032. Plexiform neurofibromas, complex nerve sheath tumors associated with neurofibromatosis...